COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs
- Alfonso J. Rodriguez-Morales(corresponding author),
- Ranjit Sah,
- Jose Millan-Oñate,
- Angel Gonzalez,
- ,
- Sias Scherger
- Fundacion Universitaria Autonoma de las Américas,
- Tribhuvan University Teaching Hospital,
- Clínica Imbanaco QuirónSalud,
- Universidad de Antioquia,
- ,
- Universidad Científica del Sur
Research Output:
Contribution to journal
Editorial
Open access
Publication Information
Output type
Research Output:
Contribution to journal
Editorial
Original language
EnglishJournal (Volume, Issue Number)
Therapeutic Advances in Infectious Disease (Volume 8)Publication milestones
- Published - 2021
Publication status
Published - 2021
ISSN
2049-9361Publication IDs
- Scopus: 85108180495
Funding Details
We dedicate this Editorial to the memory of Dr. Francisco Miguel Marty, who died tragically in 2021. Dr. Marty is remembered as a gentle, well-rounded individual with extensive expertise in mucormycosis and other opportunistic infections, including mucormycosis in organ transplant recipients and patients with malignancies. This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Access to documents
Publication metrics
Metrics
PlumX, opens in new tab
Social media
16
Citations
34
Captures
49
Sustainable Development Goals
SDG 3 Good Health and Well